Characterization of Phlebotomized Subjects and Evaluation of the Presence of Endocrine Alterations
DOI:
https://doi.org/10.18041/2390-0512/biociencias.1.11063Keywords:
Phlebotomy, hemochromatosis, polycythemia, endocrine system diseasesAbstract
Introduction: the phlebotomy is a therapeutic blood extraction procedure, indicated in hematological alterations, and since last decades, they have been related with the compromise of organs that participate in metabolism.
Objective: to describe a group of patients treated with phlebotomy in the National Blood Bank, identifying in they, the presence of diseases or clinical symptoms related to endocrinological or metabolic pathologies.
Methodology: it is an observational, descriptive and retrospective study. Were reviewed 583 medical records of patients phlebotomized, between 2010 until 2017. The statistical analysis included measures of central tendency and dispersion, besides OR and chi square for correlation evaluation.
Results: it was observed 42.36% overweight, 27.62% obesity, and presence of diseases as hypothyroidism, liver and kidney disorders, SAHOS and metabolic syndrome. in addition to classic hematological alterations, with a significant correlation between hematological and endocrine or metabolic disorders (Chi square 18.84).
Conclusion: endocrinological alterations may be present in patients with hematological alterations and this could raise the use of phlebotomy as an adjuvant in their management or prevention. Additionally, it is necessary the standardization of management protocols in the use of phlebotomy.
Downloads
References
Manrique J. La sangría: del mito al logos y del rito a la técnica. Médicos y medicina en la historia. 2002. PP5-10.
Parapia L. History of bloodletting by phlebotomy. Br J Haematol. 2008. 143(4): PP490-5. Disponible en: Doi: 10.1111 / j.1365-2141.2008.07361
Decaro J, Lemos F, Magri M. Historia de la medicina transfusional. Ediciones de la plaza. 2010. pp232. Disponible en: http://www.clausen.com.uy/img/experiencia_clinica/04_historia_medicina_transfusional.pdf
Chetty K, Light R, Stansbury D, Milne N. Exercise performance of polycythemic chronic obstructive pulmonary disease patients. Chest. 1990. 98(5): PP1073- 1077. Disponible en: Https://doi.org/10.1378/chest.98.5.1073
Casanova P, Guiral N, Andrés E, Gonzalvo C, Mateo R, Giraldo P. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Metabolism. 2011. 60(6): PP830-834. Disponible en: Https://doi.org/10.1016/j.metabol.2010.07.035
Ministerio de Salud de Colombia. Decreto 1571 de 1993. Red Nacional de Bancos de Sangre y el Consejo Nacional de Bancos de Sangre. 1993. PP5-13. Disponible en: https://www.minsalud.gov.co/Normatividad_Nuevo/DECRETO%20%201571%20DE%201993.pdf
Instituto Nacional de Salud. Guía para la selección y atención de donantes de sangre y hemocomponentes en Colombia. 2012. Disponible en: http://www.ins.gov.co
Assi T, Baz E. Current applications of therapeutic phlebotomy. Blood Transfusion. 2014. 12(1): PP75–83. Disponible en: https://doi: 10.2450/2013.0299-12
European Porphyriam Network. Porfiria cutánea tarda. Hospital Público de Paris y Comisión Europea DG sanco. 2008. Disponible en: http://porphyria.eu/es/content/porfiria-cutanea-tarda-pct
Kim K, Oh K. Clinical applications of therapeutic phlebotomy. J Med sangre. 2016. 7: PP139-144. Disponible en: http://dx.doi.org/10.2147/jbm.s108479
11. Ortiz I, Paredes J, López A, Moreno E. Hemocromatosis: etiopatogenia, diagnóstico y estrategia terapéutica, Medicine - Programa de Formación Médica Continuada Acreditado. 2012. 11(19): PP1153-1161. Disponible en: https://doi.org/10.1016/S0304-5412(12)70442-0
Batista Sabrynna. Avaliação das indicações da flebotomia terapêutica em pacientes atendidos pelo Hemovida Serviços de Hemoterapia LTDA. Universidade Federal do Rio Grande do Norte. 2018. PP32. Disponible en: https://repositorio.ufrn.br/handle/123456789/43228.
Organización Mundial de la Salud. Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad. Web OMS. 2011. Vol 11(1): PP1-7. Disponible en: http://www.who.int/vmnis/indicators/haemoglobin_es.pdf
Bautista L. Flebotomía terapéutica en pacientes con neumopatía crónica: Estudio observacional de un grupo de pacientes atendidos en un banco de sangre a 2600 msnm. Universidad Nacional de Colombia. 2015.
Keohane C, McMullin M, Harrison C. The diagnosis and management of erythrocytosis. BMJ. 2013. PP347. Disponible en: https://doi.org/10.1136/bmj.f6667
Caballero A, Torres C, Jaramillo C, Bolívar F, Sanabria F, Osorio P. Prevalence of COPD in five colombian cities situated at low, medium and high altitude (PREPOCOL study). Chest. 2008. 133(2): PP343-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17951621
Epstein L, Kristo D, Strollo J. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine. 2009. 5(3): PP263-276. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699173/
Monge C, Leon F, Arregui A. Chronic Mountain sickness in Andeans in: High Altitude. An Exploration of Human Adaptation. Lenfant C. 2001. PP815–838.
Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med. 2011. 183 (3): 292-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21037018
Echagüe G, Díaz V, Pistilli N, Ríos R, Echeverria O, Alonso E. Niveles de hemoglobina en varones fumadores. Instituto de Investigación en Ciencias de la salud. Scielo. 2005. 3(1): PP19-22. Disponible en: http://scielo.iics.una.py/pdf/iics/v3n1/v3n1a05.pdf
Sumida Y, Kanemasa K, Fukumoto K, Yoshida N, Sakai K, Nakashima T, Okanoue T. Effect of iron reductio by phlebotomy in japanese patients with nonalcoholic steatohepatitis: A pilot study. Hepatoogy research. 2006. 36(4): PP 315-321. Disponible en: Https://doi.org/10.1016/j.hepres.2006.08.003
Houschyar K, Ludtke R, Rampp T, Dobos G, Michalsen A. Phlebotomy in patients with metabolic syndrome: A randomized controlled trial. European journal of integrative medicine. 2009. 1(4): PP187-188. Disponible en: Https://doi.org/10.1016/j.eujim.2009.08.082
Brissot P, Cavey T, Ropert M, Guggenbuhl P, Loréal O. Clinical management of hemochromatosis: current perspectives. International Journal of Clinical Transfusion Medicine. 2017. 5: PP1-7. Disponible en: https://doi.org/10.2147/IJCTM.S105214
Ding R. Progress in evaluation and treatment of hepatic iron overload. Rev Linchuang Gandanbing Zazhi. Editorial Department of Journal of Clinical Hepatology. 2014. 30(9): PP961-964. Disponible en: DOI 10.3969 / j.issn.1001-5256.2014.09.031
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Biociencias
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
-
NoComercial — No puede utilizar el material para una finalidad comercial.
-
CompartirIgual — Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
- No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
